FOLFOX, Botensilimab, and Balstilimab for the Treatment of Localized Rectal Cancer Before Surgery

Clinical trial NCT06780787 · RECRUITING

Trial details

NCT number: NCT06780787
Sponsor: City of Hope Medical Center
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Rectal Adenocarcinoma Stage IIA Rectal Cancer AJCC v8 Stage III Rectal Cancer AJCC v8

Start date: 2025-05-20
Primary completion: 2027-11-05
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.